Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |